Methods for use of cryptolepine analogs with hypoglycemic activity
US5925647A · kind A · utility
2Cited by
8References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 20, 1997 |
| Grant date | Jul 20, 1999 |
| Priority date | — |
| Expiry date | Oct 20, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel cryptolepine analogs useful as hypoglycemic agents and methods for their use as hypoglycemic agents, for example, in the treatment of diabetes, and a method for their synthesis are described. As hypoglycemic agents, the novel cryptolepine analogs are useful for the treatment of insulin-dependent diabetes mellitus (IDDM or Type I) and non-insulin dependent diabetes mellitus (NIDDM or Type II).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.